150
151
10
10.3
SOURCES OF INTERFERENCE
• The EVER Pharma D‑mine
®
Pump has been tested as a class B, group 1 medical device in accordance with
IEC60601‑1‑2: 2014. It is intended for use in clinics, hospitals and domestic environments.
• The EVER PharmaD‑m ine
®
Pump delivers apomorphine. Using the device in the vicinity of strong electromagnetic
fields can impair or impede performance. In such cases, the EVER PharmaD‑mine
®
Pump may signal that an error
has occurred.
• Avoid using the EVER PharmaD‑m ine
®
Pump in the vicinity of active electrosurgical instruments and within RF
shielded rooms for MRT at medical facilities where the electromagnetic wave intensity is high.
• The use of the EVER PharmaD‑mine
®
Pump in the vicinity of or in connection with other devices should be avoided
because this can lead to malfunctions.
• The use of accessories, converters or cables that are not intended for or supplied with the EVER PharmaD‑mine
®
Pump can result in increased electromagnetic emissions, reduced electromagnetic immunity, and malfunctioning
of the pump.
ELECTROMAGNETIC EMISSIONS
• Portable RF communications equipment (including peripheral devices, such as antenna cables and external antennae)
should not be used at a distance of less than 30cm or 12inches from any part of the EVER PharmaD‑mine
®
Pump,
including cables. Such equipment includes mobile phones, wireless phones, and wireless computer devices.
Otherwise the performance of the EVER PharmaD‑mine
®
Pump may be reduced.
RF emissions CISPR 11
Group 1 Class B
Harmonic emissions
IEC 61000‑3‑2
Class A
Voltage fluctuations/flicker
emissions
IEC 61000‑3‑3
dmax < 4% dmax < 4%